Mr. Gurney spoke about several recent high profile criminal cases as part of a panel called "An Exploration of Ethical Issues Raised by Stevens, Stryker Biotech, and Similar Cases" at the Food and Drug Law Institute Annual Conference on April 25, 2012.
Mr. Gurney spoke in a panel entitled "Anatomy of a Health Care Fraud Case: Lessons from Stryker" at the Boston Bar Association Health Care Fraud 2012 CLE Program on April 10, 2012.
Mr. Gurney spoke in the panel "A Year in Legal Insight: Developments to Meet a Rapidly Evolving Industry" at the Park Plaza Hotel in Boston which was part of the Medical Devices Summit 2012 produced by Opal Events on March 7, 2012.
Mr. Gurney presented "Disturbing Developments: Increased Strict Liability Prosecutions of Corporate Officers: The Crime of Doing Nothing” at the FDLI Enforcement and Litigation Conference in Washington DC on October 13, 2010.
Mr. Gurney presented "The Crime of Doing Nothing: Strict Liability for Corporate Officers under FDCA” at the FDLI Enforcement and Litigation Conference in Washington DC on October 13, 2009.
Mr. Gurney also presented "Problems and Pitfalls for In-House Counsel: Personal Liability of Corporate Counsel” at the Personal Care Products Council's 2009 Legal and Regulatory Conference in Vancouver, British Columbia on June 18, 2009.
Mr. Gurney was quoted in The Daily Record on October 5, 2008. He discussed a recent law amending the Federal Rules of Evidence and limiting the circumstances under which attorney-client privilege is waived during discovery in the article, "New Rule Curbs Inadvertent Waiver.”
Mr. Gurney was quoted in the September 30, 2008 article, "Embracing 502, the New Hope for Attorney-Client Privilege,” which appeared in Compliance Week.
Mr. Gurney was quoted in the September 29, 2008 article, "New Discovery Rule to Curb Accidental Privilege Waiver,” which appeared in Massachusetts Lawyers Weekly, discussing a newly signed law that amends the Federal Rules of Evidence.
Mr. Gurney was quoted in the March 2008 issue of the RPM Report article, "No Walk in the Park: FDA Talks Tough About Executive Accountability” discussing the applicability of the Park Doctrine in strict liability prosecutions in the pharmaceutical industry, under the Food Drug & Cosmetic Act.
Mr. Gurney was quoted in the July 6, 2007 issue of Rx Compliance Report discussing strict liability prosecutions in the pharmaceutical industry under the responsible corporate officer doctrine.
Mr. Gurney was quoted in U.S. News & World Report concerning trends in white-collar crime: "The Crackdown Cracks, Getting tough on corporate crime is so yesterday. The pendulum is swinging back, hitting everyone from gumshoes to judges,” U.S. News & World Report, April 24, 2006 (available at www.usnews.com).